In 2021, Hospital-Based Laboratories Segment is Expected to Dominate the Global Clinical Laboratory Services Market with 64.4% Market Share

 

The prevalence of infectious diseases and chronic illnesses is increasing globally. Since clinical diagnostic tests are one of the most precise ways to identify and characterize different biomarkers of chronic diseases as well as to detect microorganisms, their demand is rising along with the prevalence of illnesses such as cancer and tuberculosis (TB). For instance, according to the World Health Organization's October 2021 update, 10 million individuals worldwide contracted tuberculosis in 2020, of which 5.6 million men, 3.3 million women, and 1.1 million children.   ​

Access Full Report at https://www.databridgemarketresearch.com/reports/global-clinical-laboratory-services-market

The global clinical laboratory services market is expected to reach USD 4,43,369.94 million by 2028 from USD 2,56,405.24 million in 2020, growing at a CAGR of 7.2% in the forecast period of 2021 to 2028. The market demand is accelerating due to the aging population, rising chronic disease rates, and diseases linked to lifestyle choices. The growing prevalence of chronic diseases, particularly in the elderly population, is promoting market expansion.   

Clinical Laboratory Services Market

Increased prevalence of infectious diseases will drive the market's growth rate

Increasing cases of infectious diseases are the main leading reason for death worldwide, especially in low-income countries. Infectious diseases affected by the organisms such as viruses, parasites, fungi, and bacteria are directly or indirectly passed from one person to another. Increasing infectious diseases impact on increasing the demand for clinical laboratories because of laboratory diagnosis of infectious disease of the patients. The clinical laboratory provides different types of services for diagnosing and treating patients due to infectious diseases, including blood count, immunology and allergy testing, and urinalysis, among others. This is driving the growth of the market. Increased expenditure by public and private players on infrastructure development will also promote the market growth rate. Continuous research and development pertaining to the deployment of advanced technologies will yet again widen the scope of growth.  

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2021 to 2028

Base Year

2020

Historic Years

2019 (Customizable to 2013 - 2018)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Specialty (Clinical Chemistry Testing, Hematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing and Genetic Testing), Provider (Independent and Reference Laboratories, Hospital-Based Laboratories and Nursing and Physician Office-Based Laboratories), Application (Drug Discovery Related Services, Drug Development Related Services, Bioanalytical and Lab Chemistry Services, Toxicology Testing Services, Cell and Gene Therapy Related Services, Preclinical and Clinical Trial Related Services and Other Clinical Laboratory Services), Service Type (Routine Testing Services, Esoteric Services And Anatomic Pathology Services)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Mayo Foundation for Medical Education and Research (MFMER) (US), Laboratory Corporation of America Holding (US), Quest Diagnostics Incorporated (US), DaVita Inc. (US), Eurofins Scientific (France), SYNLAB International GmbH (Germany), H.U. Groups Holdings, Inc. (Tokyo), Sonic Healthcare (Australia), ACM Global Laboratories (India), Amedes Holding GmbH (Germany), LifeLabs (Canada), Abbott (US), Charles River (US), Siemens Healthineers AG (Germany), BioReference Laboratories, Inc. (US), NeoGenomics Laboratories, Inc. (US), KingMed Diagnostics (China), Genomic Health (US), and ARUP Laboratories (US) among others.             

Data Points Covered in the Report

In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

Global clinical laboratory services market is categorized into four notable segments which are based on basis of specialty, provider, application and service type.

  • On the basis of specialty, the market is segmented into clinical chemistry testing, microbiology testing, hematology testing, immunology testing, cytology testing, genetic testing and drugs of abuse testing. In 2021, clinical chemistry testing segment is expected to dominate the global clinical laboratory services market with a 51.8% market share due to the rise in chronic diseases such as liver diseases, cardiovascular diseases and blood disorders which are increasing the demand to use clinical chemistry services. In addition, the increase in demand for point of care testing solutions, which are used for the fast diagnosis of the disease, is expected to help the market to grow significantly.
  • On the basis of provider, the market is segmented into independent & reference laboratories, hospital-based laboratories, nursing and physician office-based laboratories. In 2021, hospital-based laboratories segment is expected to dominate the global clinical laboratory services market with 64.4% market share due to the increase in cases of injuries in the hospitals, leading to high patient volumes and high test demand.
  • On the basis of application, the market is segmented into drug discovery related services, drug development related services, bioanalytical & lab chemistry services, toxicology testing services, cell & gene therapy related services, preclinical & clinical trial related services and other clinical laboratory services. In 2021, bioanalytical & lab chemistry services segment is expected to dominate the global clinical laboratory services market with 46.3% market share because bioanalysis is an important factor in drug discovery and development. It is established that bioanalysis is a vital part of the pharmacokinetic/pharmacodynamics categorization of a novel chemical entity from its discovery and in different phases of drug development, including all preclinical and clinical stages.

The bioanalytical & lab chemistry services segment will dominate the application segment of the clinical laboratory services market

The bioanalytical & lab chemistry services segment will emerge as the dominating segment under application segment in 2021. This is because of the growing number of bioanalytical and chemistry labs all over the globe. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.

  • On the basis of service type, the market is segmented into routine testing services, esoteric services and anatomic pathology services. In 2021, routine testing services segment is expected to dominate the global clinical laboratory services market with 75.9% market share due to the growing cases of chronic diseases such as liver diseases, cardiovascular diseases, and blood disorders, increasing the demand to use research and development.

The routine testing services segment will dominate the service type segment of the clinical laboratory services market

The routine testing services segment will emerge as the dominating segment under service type in 2021 with approximately 76% market share. This is because of the growing number of hospitals in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.

Major Players              

Data Bridge Market Research recognizes the following companies as the market players in clinical laboratory services market: Mayo Foundation for Medical Education and Research (MFMER) (US), Laboratory Corporation of America Holding (US), Quest Diagnostics Incorporated (US), DaVita Inc. (US), Eurofins Scientific (France), Amedes Holding GmbH (Germany), LifeLabs (Canada), Abbott (US), Charles River (US), Siemens Healthineers AG (Germany), BioReference Laboratories, Inc. (US), NeoGenomics Laboratories, Inc. (US), and ARUP Laboratories (US).

Clinical Laboratory Services Market

Market Development

  • In May 2021, LifeLabs announced that it has partnered with Telus Health to offer MyCareCompass customers in Ontario and improve access to allied health services such as virtual counseling through Babylon by TELUS Health virtual care service
  • In June 2021, Abbott announced it had received CE Mark and Health Canada approval for its Amplatzer Steerable Delivery Sheath, used with its market-leading Amplatzer Amulet Left Atrial Appendage (LAA) Occluder. Now available in Europe and Canada, the new device is the first steerable delivery sheath that has been developed specifically for minimally invasive LAA occlusion (or closure) procedures to treat patients diagnosed with atrial fibrillation who are at risk of ischemic stroke

Regional Analysis

Geographically, the countries covered in the clinical laboratory services market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

North America is the dominant region in clinical laboratory services market during the forecast period 2021 - 2028

Because of the substantial investment in the region for adopting new healthcare facilities, North America is likely to lead the global market. In addition, the region's market is fueled by the presence of major competitors, increase in need for support from clinical laboratory services for efficient treatment and patient care within the region and early adoption of advanced products.

Asia-Pacific is estimated to be the fastest-growing region in clinical laboratory services market the forecast period 2021 - 2028

Asia-Pacific is expected to increase significantly as well and will register the highest growth rate owing to an increase in the region's pet population and increased investments in the healthcare sector. Furthermore, as part of their economic growth aspirations, growing economies in APAC, such as India, are heavily investing in infrastructure development. Furthermore, due to the growing unmet medical needs increasing scientific research in the region and increasing investment by multiple organizations in product research and development, particularly in manufacturing in developing countries, is fueling market expansion in the region.

COVID-19 Impact Analysis

Given that the COVID-19 pandemic has increased demand for clinical laboratory testing services, the COVID-19 outbreak is anticipated to benefit the clinical laboratory services sector. It was discovered that the clinical diagnostics and technologies, including molecular and serological testing methodologies for severe acute respiratory syndrome–coronavirus 2 (SARS–CoV2) testing, had improved based on the study published in National Center for Biotechnology Information in July 2020. Improvements in clinical diagnostics and testing technology have also led to an increase in the number of rapid and broad testing advances, which has contributed to the rise in overall demand.

For more detailed information about the clinical laboratory services on market report, click here – https://www.databridgemarketresearch.com/reports/global-clinical-laboratory-services-market